Tive hepatitis by autoantibodies against a soluble liver antigen. Lancet 1987, 7:29294. 3. Kanzler S, Weidemann C, Gerken G, L r HF, Galle PR, Meyer zum B chenfelde KH, Lohse AW: Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis. J Hepatol 1999, 31:63540. four. Wies I, Brunner S, Henninger J, Herkel J, Kanzler S, Meyer zum B chenfelde KH, Lohse AW: Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet 2000, 355:1510515. five. Gelpi C, Sontheimer EJ, Rodriguez-Sanchez JL: Autoantibodies against a serine tRNA-protein complicated implicated in cotranslational selenocysteine insertion. Proc Natl Acad Sci U S A 1992, 89:9739743. six. Paiardini A, Bossa F, Pascarella S: Evolutionarily conserved regions and hydrophobic contacts at the superfamily level: The case with the fold-type I pyridoxal-50-phosphate-dependent enzymes. Protein Sci 2004, 13:2992005. 7. Singh R, Spyrakis F, Cozzini P, Paiardini A, Pascarella S, Mozzarelli A: Chemogenomics of pyridoxal 50-phosphate dependent enzymes. J Enzyme Inhib Med Chem 2013, 28:18394. 8. Cellini B, Bertoldi M, Montioli R, Paiardini A, Borri Voltattorni C: Human wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implications. Biochem J 2007, 408:390. 9. di Salvo ML, Florio R, Paiardini A, Vivoli M, D’Aguanno S, Contestabile R: Alanine racemase from Tolypocladium inflatum: a key PLP-dependent enzyme in cyclosporin biosynthesis along with a model of catalytic promiscuity. Arch Biochem Biophys 2013, 529:555. 10. Yuan J, Palioura S, Salazar JC, Su D, O’Donoghue P, Hohn MJ, Cardoso AM, Whitman WB, S l D: RNA-dependent conversion of phosphoserine forms selenocysteine in eukaryotes and archaea. Proc Natl Acad Sci U S A 2006, 103:189238927. 11. Czaja AJ: Autoimmune hepatitis pproach to diagnosis. MedGenMed 2006, 23:55. 12. Czaja AJ, Strettell MD, Thomson LJ, Santrach PJ, Moore SB, Donaldson PT, Williams R: Associations among alleles from the significant histocompatibility complicated and sort 1 autoimmune hepatitis. Hepatology 1997, 25:31723. 13. McFarlane IG: Definition and classification of autoimmune hepatitis. Semin Liver Dis 2002, 22:31724. 14. Czaja AJ, Donaldson PT: Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis. Immunol Rev 2000, 174:25059. 15. Mix H, Weiler-Normann C, Thimme R, Ahlenstiel G, Shin EC, Herkel J, David CS, Lohse AW, Rehermann B: Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis.GCGRhttps://www.medchemexpress.com/GLP-17-36.html }GLP-1(7-36), amide Biological Activity|GLP-1(7-36), amide In stock|GLP-1(7-36), amide manufacturer|GLP-1(7-36), amide Autophagy} Gastroenterology 2008, 135:2107118.Sennoside A Formula 16.PMID:24455443 Herkel J, Heidrich B, Nieraad N, Wies I, Rother M, Lohse AW: Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas. Hepatology 2002, 35:40308. 17. Lunardi C, Bason C, Navone R, Millo E, Damonte G, Corrocher R, Puccetti A: Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med 2000, 6:1183186. 18. Wang CX, Teufel A, Cheruti U, Gr zinger J, Galle PR, Lohse AW, Herkel J: Characterization of human gene encoding SLA/LP autoantigen and its conserved homologs in mouse fish fly and worm. Planet J Gastroenterol 2006, 12:90207. 19. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Sayers EW: GenBank. Nucleic Acids Res 2011, 39:D32 37. 20. Berman HM, Kleywegt GJ, Nakamura H, Markley JL: The Protein Data Bank at 40: reflecting on the p.